Wrong Number, Please Try Again

Making sense of the mass of numbers in the president's budget isn't easy, even for administration officials who have played a role in developing them. For example, at his news conference held the day the budget was released, presidential science adviser Allan Bromley declared that military spending in the 1993 proposed budget represents only 53 percent of the total R&D budget request. Several articles in the national media cited that number as proof that the Bush administration has shifted it

Written byJeffrey Mervis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

For example, at his news conference held the day the budget was released, presidential science adviser Allan Bromley declared that military spending in the 1993 proposed budget represents only 53 percent of the total R&D budget request. Several articles in the national media cited that number as proof that the Bush administration has shifted its priorities toward applied civilian science.

Actually, that figure is incorrect, says an official in Bromley's Office of Science and Technology Policy. "Go with what's in the budget [59 percent]," says the official, who requests anonymity. "That's the right number. We can't figure out where he got the [53 percent] number."

A second example involves the new presidential initiative in biotechnology, one high-tech area in which U.S. industry holds a commanding lead over the rest of the world. The budget notes that the Bush administration has requested $4.03 billion, a 7 percent increase over current spending, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies